Novavax, Inc.

Company Name: Novavax, Inc.

Novavax, Inc. is a clinical stage vaccine company. The company is engaged in the development of recombinant nanoparticle vaccines and adjuvants. The company’s pipeline includes vaccine candidates for a range of infectious diseases including:

Ticker Symbol: NVAX (NASDAQ)